Functions of E3 Ubiquitin Ligase Hyd in Drosophila Tissues

被引:0
|
作者
Galimova, I. A. [1 ]
Dorogova, N. V. [2 ]
Fedorova, S. A. [2 ]
机构
[1] Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk 630090, Russia
[2] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia
关键词
ubiquitination; E3 ubiquitin ligase; tumor suppressor; non-proteolytic functions; TUMOR-SUPPRESSOR GENE; PROTEIN LIGASE; OVARIAN-CANCER; HECT FAMILY; UBR5; DOMAIN; MELANOGASTER; EDD; RECOGNITION; RESISTANCE;
D O I
10.1134/S0026893321020205
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin-proteasome system (UPS) is an important regulator of the main cellular processes. The components of the UPS are involved in the regulation of the cell cycle, signal transduction, the cell response to DNA damage, metabolism, and transcription control. E3 ubiquitin ligases (the enzymes that covalently attaches ubiquitin to target proteins) play a key role in the functioning of the UPS. The Drosophila tumor suppressor Hyd (hyperplastic discs) is one of the most interesting E3 ligases; it is required for the regulation of proliferation, growth, and cell differentiation. The study of hyd mutations in different tissues of Drosophila demonstrated that depending on the cellular context, Hyd can not only perform proteolytic functions associated with protein degradation, but can also, interacting with other proteins and/or nucleic acids, act as an important regulator of cellular processes.
引用
收藏
页码:305 / 310
页数:6
相关论文
共 50 条
  • [41] E3 ubiquitin ligases: styles, structures and functions
    Quan Yang
    Jinyao Zhao
    Dan Chen
    Yang Wang
    Molecular Biomedicine, 2
  • [42] A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders
    George, Arlene J.
    Hoffiz, Yarely C.
    Charles, Antoinette J.
    Zhu, Ying
    Mabb, Angela M.
    FRONTIERS IN GENETICS, 2018, 9
  • [43] Cryo-EM structure of the chain-elongating E3 ubiquitin ligase UBR5
    Hodakova, Zuzana
    Grishkovskaya, Irina
    Brunner, Hanna L.
    Bolhuis, Derek L.
    Belacic, Katarina
    Schleiffer, Alexander
    Kotisch, Harald
    Brown, Nicholas G.
    Haselbach, David
    EMBO JOURNAL, 2023, 42 (16)
  • [44] The ECS(SPSB) E3 ubiquitin ligase is the master regulator of the lifetime of inducible nitric-oxide synthase
    Matsumoto, Kazuma
    Nishiya, Tadashi
    Maekawa, Satoshi
    Horinouchi, Takahiro
    Ogasawara, Kouetsu
    Uehara, Takashi
    Miwa, Soichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (01) : 46 - 51
  • [45] Essential Role of E3 Ubiquitin Ligase Activity in Cbl-b-Regulated T Cell Functions
    Paolino, Magdalena
    Thien, Christine B. F.
    Gruber, Thomas
    Hinterleitner, Reinhard
    Baier, Gottfried
    Langdon, Wallace Y.
    Penninger, Josef M.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (04) : 2138 - 2147
  • [46] The Drosophila MCPH1-B isoform is a substrate of the APCCdh1 E3 ubiquitin ligase complex
    Hainline, Sarah G.
    Rickmyre, Jamie L.
    Neitzel, Leif R.
    Lee, Laura A.
    Lee, Ethan
    BIOLOGY OPEN, 2014, 3 (07): : 669 - 676
  • [47] The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5
    Zhang, Huan-Tian
    Zeng, Ling-Fei
    He, Qing-Yu
    Tao, W. Andy
    Zha, Zhen-Gang
    Hu, Chang-Deng
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (02): : 335 - 346
  • [48] NEDD4 E3 ligase: Functions and mechanism in human cancer
    Wang, Zhi-Wei
    Hu, Xiaoli
    Ye, Miaomiao
    Lin, Min
    Chu, Man
    Shen, Xian
    SEMINARS IN CANCER BIOLOGY, 2020, 67 : 92 - 101
  • [49] The anaphase-promoting complex/cyclosome is an E3 ubiquitin ligase for Mdm2
    He, Yizhou
    Tollini, Laura
    Kim, Tae-Hyung
    Itahana, Yoko
    Zhang, Yanping
    CELL CYCLE, 2014, 13 (13) : 2101 - 2109
  • [50] Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1
    Wang, Guanghui
    Zhuang, Zi
    Shen, Siyuan
    Yang, Fan
    Jiang, Zhiyuan
    Liu, Ziping
    Wang, Tianshi
    Hua, Lei
    HUMAN CELL, 2022, 35 (03) : 896 - 908